Author:
Heerema Nyla A.,Raimondi Susana Catalina
Publisher
Springer International Publishing
Reference178 articles.
1. WHO. World health organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
2. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, Squire JA. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood. 2001;97(11):3581–8.
3. Gulley ML, Shea TC, Fedoriw Y. Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. J Mol Diagn. 2010;12(1):3–16.
4. Mrozek K, Prior TW, Edwards C, Marcucci G, Carroll AJ, Snyder PJ, Koduru PR, Theil KS, Pettenati MJ, Archer KJ, Caligiuri MA, Vardiman JW, Kolitz JE, Larson RA, Bloomfield CD. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a cancer and leukemia group b study. J Clin Oncol. 2001;19(9):2482–92.
5. Campbell LJ, Oei P, Brookwell R, Shortt J, Eaddy N, Ng A, Chew E, Browett P. Fish detection of pml-rara fusion in ins(15;17) acute promyelocytic leukaemia depends on probe size. Biomed Res Int. 2013;2013:164501.